Pharmaceutical company HRA Pharma submitted an application to the Food and Drug Administration on Monday asking to sell a birth control bill over-the-counter, rather than via prescription.
If approved, it would be the first ever birth control pill to be available over-the-counter in the U.S. The application was submitted just weeks after the Supreme Court overturned Roe v. Wade, putting contraception access back into the spotlight.
“This historic application marks a groundbreaking moment in contraceptive access and reproductive equity in the U.S.,” Frédérique Welgryn, Chief Strategic Operations and Innovation Officer at HRA Pharma, said in the press release.
Read the full article.
If approved, HRA Pharma’s drug would be the first ever birth control pill available over the counter in the U.S.https://t.co/AikRfDWuqh
— Axios (@axios) July 11, 2022